Clinical Trial Update: A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older

View source ↗

Summary

A Pfizer-sponsored study is evaluating how well Prevnar 20 works to prevent pneumonia in adults aged 65 and older; the trial is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Prevnar 20 (20-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Community-Acquired Pneumonia (CAP) | Status: ACTIVE_NOT_RECRUITING